204 related articles for article (PubMed ID: 28285755)
1. [The human and economic burden of cancer in France in 2014, based on the Sniiram national database].
Tuppin P; Pestel L; Samson S; Cuerq A; Rivière S; Tala S; Denis P; Drouin J; Gissot C; Gastaldi-Ménager C; Fagot-Campagna A
Bull Cancer; 2017 Jun; 104(6):524-537. PubMed ID: 28285755
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
4. [The cost of chemotherapy].
Lévy C; Bonastre J
Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
[TBL] [Abstract][Full Text] [Related]
5. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
6. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
[TBL] [Abstract][Full Text] [Related]
7. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
8. [Cost of cancer in France: pharmaceutical expenditure as part of global patients' care].
Zambrowski JJ
Bull Cancer; 2008 May; 95(5):535-41. PubMed ID: 18541518
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. [Methodological standards for cost-of-illness studies using breast cancer, prostate cancer and colon cancer as an example].
Damm O; Hodek JM; Greiner W
Z Evid Fortbild Qual Gesundhwes; 2009; 103(6):305-16. PubMed ID: 19839202
[TBL] [Abstract][Full Text] [Related]
11. [COART France 2003 report on new socioeconomic data on osteoarthritis in France].
Solignac M
Presse Med; 2004 May; 33(9 Pt 2):S4-6. PubMed ID: 15226681
[TBL] [Abstract][Full Text] [Related]
12. [Health care use by free complementary health insurance coverage beneficiaries in France in 2012].
Tuppin P; Samson S; Colinot N; Gastaldi-Menager C; Fagot-Campagna A; Gissot C
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):67-78. PubMed ID: 26915427
[TBL] [Abstract][Full Text] [Related]
13. Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US.
Zaorsky NG; Khunsriraksakul C; Acri SL; Liu DJ; Ba DM; Lin JL; Liu G; Segel JE; Drabick JJ; Mackley HB; Leslie DL
JAMA Netw Open; 2021 Oct; 4(10):e2127784. PubMed ID: 34613403
[TBL] [Abstract][Full Text] [Related]
14. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
15. Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries).
Doat S; Samson S; Fagot-Campagna A; Tuppin P; Menegaux F
Rev Epidemiol Sante Publique; 2016 Jun; 64(3):145-52. PubMed ID: 27238161
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of trends in the cost of initial cancer treatment.
Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
[TBL] [Abstract][Full Text] [Related]
17. Estimates and projections of value of life lost from cancer deaths in the United States.
Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
[TBL] [Abstract][Full Text] [Related]
18. Projections of the cost of cancer care in the United States: 2010-2020.
Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
Vandhuick O; Payet M; Préaud E; Lortet-Tieulent J; Raguideau F; Chevreuil O; van Hille B; Kwiatkowski A
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1135-1144. PubMed ID: 34165377
[TBL] [Abstract][Full Text] [Related]
20. The annual costs of cardiovascular diseases and mental disorders attributable to job strain in France.
Sultan-Taïeb H; Chastang JF; Mansouri M; Niedhammer I
BMC Public Health; 2013 Aug; 13():748. PubMed ID: 23941511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
